Diabetes being a chronic multisystem disease with end-organ damage, it would be natural to expect raised serum EPO, especially with coexisting nephropathy and anaemia.
We appreciate the comments of Dr Uparkar regarding our article. We agree that serum erythropoietin (EPO) is expected to be raised in diabetic patients. However, we showed that vitreous EPO levels were raised because of intraocular production in our earlier article. 1 Dr Uparkar states that it would be fallacious to compare the acute imbalance or retinal vein occlusions with diabetic macular oedema (DME), a chronic condition. However, other vitreous factors, such as vascular endothelial growth factor (VEGF), are raised in both diseases; 2, 3 hence, we believe our study is not so fallacious. We agree that systemic factors are related with EPO production, but we remind Dr Uparkar that, as mentioned above, intraocular production was responsible for raised vitreous EPO levels. 1 
